Historical source coverage

2015

109 selected records with a cited source date in 2015. This archive is selective and does not imply continuous monitoring or complete historical coverage.

Explore 2015 by record type

3 types

December 2015

13 records

Clinical trials · Daptomycin

ClinicalTrials.gov record NCT00663403

PeptideScanner retained ClinicalTrials.gov record NCT00663403 at 2026-11-15T22:01:45.056Z. Its registry update date was 2015-12-30, and PeptideScanner's reviewed identity mapping was daptomycin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Cetrorelix

ClinicalTrials.gov record NCT02640976

PeptideScanner retained ClinicalTrials.gov record NCT02640976 at 2026-11-15T22:02:39.332Z. Its registry update date was 2015-12-29, and PeptideScanner's reviewed identity mapping was cetrorelix.

Source: ClinicalTrials.gov ↗

→

Regulatory · Glatiramer acetate

Federal Register proposed rule 2015-32246

The Federal Register published proposed rule 2015-32246, attributed to FDA and its parent HHS department, on 2015-12-23. Its official title is “Fixed-Combination and Co-Packaged Drugs: Applications for Approval and Combinations of Active Ingredients Under Consideration for Inclusion in an Over-the-Counter Monograph,” and PeptideScanner's exact reviewed identity mapping connects the document to Glatiramer.

Source: Federal Register via GovInfo ↗

→

Clinical trials · Octreotide

ClinicalTrials.gov record NCT01917773

PeptideScanner retained ClinicalTrials.gov record NCT01917773 at 2026-07-30T21:39:57.679Z. Its registry update date was 2015-12-21, and PeptideScanner's reviewed identity mapping was octreotide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Glatiramer acetate

Demonstration of equivalence of a generic glatiramer acetate (Glatopa™).

PubMed lists PMID 26671082 in Journal of the neurological sciences as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2015-10-08 (day precision). PeptideScanner associated the retained record with the identity slug glatiramer-acetate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Lixisenatide

ClinicalTrials.gov record NCT02020629

PeptideScanner retained ClinicalTrials.gov record NCT02020629 at 2026-07-30T21:39:57.678Z. Its registry update date was 2015-12-15, and PeptideScanner's reviewed identity mapping was lixisenatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Ziconotide

ClinicalTrials.gov record NCT00076544

PeptideScanner retained ClinicalTrials.gov record NCT00076544 at 2026-07-30T21:39:57.683Z. Its registry update date was 2015-12-14, and PeptideScanner's reviewed identity mapping was ziconotide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Pasireotide

ClinicalTrials.gov record NCT02622906

PeptideScanner retained ClinicalTrials.gov record NCT02622906 at 2026-11-15T22:05:38.400Z. Its registry update date was 2015-12-07, and PeptideScanner's reviewed identity mapping was pasireotide.

Source: ClinicalTrials.gov ↗

→

November 2015

22 records

Literature metadata · Secretin

[Secretin].

PubMed lists PMID 16149565 in Nihon rinsho. Japanese journal of clinical medicine as Journal Article, Review, with publication-date metadata of 2005-08 (month precision). PeptideScanner associated the retained record with the identity slug secretin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Glatiramer acetate

Glatiramer acetate for treatment of relapsing-remitting multiple sclerosis.

PubMed lists PMID 22449210 in Expert review of neurotherapeutics as Journal Article, Review, with publication-date metadata of 2012-04 (month precision). PeptideScanner associated the retained record with the identity slug glatiramer-acetate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Glatiramer acetate

The use of interferon Beta and glatiramer acetate in multiple sclerosis.

PubMed lists PMID 23709209 in Seminars in neurology as Journal Article, Review, with publication-date metadata of 2013-05-25 (day precision). PeptideScanner associated the retained record with the identity slug glatiramer-acetate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Gonadorelin

Gonadorelin--synthetic LH-RH.

PubMed lists PMID 6358816 in The Medical letter on drugs and therapeutics as Journal Article, with publication-date metadata of 1983-11-25 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Liraglutide

[Basal insulin and liraglutide combined in a pen].

PubMed lists PMID 26364391 in Medizinische Monatsschrift fur Pharmazeuten as Journal Article, with publication-date metadata of 2015-04 (month precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Liraglutide

New drugs: Liraglutide, dalfampridine, and abobotulinumtoxinA.

PubMed lists PMID 20452924 in Journal of the American Pharmacists Association : JAPhA as Journal Article, with publication-date metadata of 2010 May-Jun (source-text precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Liraglutide

Liraglutide in islet transplantation: from bench to bedside.

PubMed lists PMID 20456108 in Transplant international : official journal of the European Society for Organ Transplantation as Comment, Journal Article, with publication-date metadata of 2010-03-01 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Liraglutide

Liraglutide therapy in Prader-Willi syndrome.

PubMed lists PMID 21388446 in Diabetic medicine : a journal of the British Diabetic Association as Case Reports, Letter, Research Support, Non-U.S. Gov't, with publication-date metadata of 2011-06 (month precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Liraglutide

[Liraglutide].

PubMed lists PMID 21595276 in Nihon rinsho. Japanese journal of clinical medicine as English Abstract, Journal Article, Review, with publication-date metadata of 2011-05 (month precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Liraglutide

[Liraglutide in the treatment of diabetes type 2].

PubMed lists PMID 22165195 in Lijecnicki vjesnik as English Abstract, Journal Article, Review, with publication-date metadata of 2011 Jul-Aug (source-text precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Liraglutide

Combination therapy with liraglutide and sulfonylurea for a type 2 diabetic patient with high titer of anti-insulin antibodies produced by insulin therapy.

PubMed lists PMID 22257418 in Diabetes research and clinical practice as Case Reports, Letter, with publication-date metadata of 2012-01-16 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Liraglutide

[Acute pancreatitis in a patient treated with liraglutide].

PubMed lists PMID 23507272 in Medicina clinica as Case Reports, Letter, with publication-date metadata of 2013-03-15 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Liraglutide

Liraglutide in combination with acitretin for severe recalcitrant psoriasis.

PubMed lists PMID 23834125 in The British journal of dermatology as Case Reports, Letter, with publication-date metadata of 2013-07 (month precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Liraglutide

Acute interstitial nephritis after treatment with liraglutide.

PubMed lists PMID 24315766 in American journal of kidney diseases : the official journal of the National Kidney Foundation as Case Reports, Letter, with publication-date metadata of 2013-12-04 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Liraglutide

Liraglutide treatment in a patient with HIV, type 2 diabetes and sleep apnoea-hypopnoea syndrome.

PubMed lists PMID 25455831 in Diabetes & metabolism as Case Reports, Letter, with publication-date metadata of 2014-11-06 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Exenatide

PubMed record PMID 22997980

PeptideScanner retained PubMed bibliographic metadata for PMID 22997980 at 2026-07-30T21:41:09.514Z. PubMed recorded a metadata revision date of 2015-11-19 and an Entrez history date of 2012-09-25. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Bremelanotide

PubMed record PMID 14999221

PeptideScanner retained PubMed bibliographic metadata for PMID 14999221 at 2026-07-30T21:41:07.288Z. PubMed recorded a metadata revision date of 2015-11-19 and an Entrez history date of 2004-03-05. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Bremelanotide

PubMed record PMID 15833522

PeptideScanner retained PubMed bibliographic metadata for PMID 15833522 at 2026-07-30T21:41:07.293Z. PubMed recorded a metadata revision date of 2015-11-19 and an Entrez history date of 2005-04-19. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Clinical trials · Metreleptin

ClinicalTrials.gov record NCT00710814

PeptideScanner retained ClinicalTrials.gov record NCT00710814 at 2026-11-16T17:35:38.955Z. Its registry update date was 2015-11-16, and PeptideScanner's reviewed identity mapping was metreleptin.

Source: ClinicalTrials.gov ↗

→

October 2015

7 records

Clinical trials · Triptorelin

ClinicalTrials.gov record NCT01160315

PeptideScanner retained ClinicalTrials.gov record NCT01160315 at 2026-11-15T21:49:16.513Z. Its registry update date was 2015-10-30, and PeptideScanner's reviewed identity mapping was triptorelin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Triptorelin

ClinicalTrials.gov record NCT02102646

PeptideScanner retained ClinicalTrials.gov record NCT02102646 at 2026-11-15T21:49:16.513Z. Its registry update date was 2015-10-28, and PeptideScanner's reviewed identity mapping was triptorelin.

Source: ClinicalTrials.gov ↗

→

Literature metadata · PEG-MGF

Examination of alternate codon bias solutions for expression and purification of recombinant mechano-growth factor in Escherichia coli.

PubMed lists PMID 25345350 in Biotechnology and applied biochemistry as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-08-06 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Desmopressin

ClinicalTrials.gov record NCT01223937

PeptideScanner retained ClinicalTrials.gov record NCT01223937 at 2026-11-16T01:33:21.554Z. Its registry update date was 2015-10-15, and PeptideScanner's reviewed identity mapping was desmopressin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Desmopressin

ClinicalTrials.gov record NCT01262456

PeptideScanner retained ClinicalTrials.gov record NCT01262456 at 2026-11-16T01:33:21.554Z. Its registry update date was 2015-10-15, and PeptideScanner's reviewed identity mapping was desmopressin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01753856

PeptideScanner retained ClinicalTrials.gov record NCT01753856 at 2026-07-30T21:39:57.682Z. Its registry update date was 2015-10-08, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

→

September 2015

3 records

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01360424

PeptideScanner retained ClinicalTrials.gov record NCT01360424 at 2026-07-30T21:41:27.767Z. Its registry update date was 2015-09-29, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01785043

PeptideScanner retained ClinicalTrials.gov record NCT01785043 at 2026-07-30T21:41:27.766Z. Its registry update date was 2015-09-15, and PeptideScanner's reviewed identity mapping was liraglutide.

Source: ClinicalTrials.gov ↗

→

Regulatory · Glucagon

Federal Register notice 2015-22673

The Federal Register published notice 2015-22673, attributed to FDA and its parent HHS department, on 2015-09-09. Its official title is “Determination That GLUCAGON (Glucagon Hydrochloride) for Injection, Equivalent to 1 Milligram Base/Vial and Equivalent to 10 Milligram Base/Vial, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon.

Source: Federal Register via GovInfo ↗

→

August 2015

3 records

Clinical trials · Desmopressin

ClinicalTrials.gov record NCT01606072

PeptideScanner retained ClinicalTrials.gov record NCT01606072 at 2026-11-16T01:33:21.554Z. Its registry update date was 2015-08-28, and PeptideScanner's reviewed identity mapping was desmopressin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00005006

PeptideScanner retained ClinicalTrials.gov record NCT00005006 at 2026-07-30T21:41:27.764Z. Its registry update date was 2015-08-19, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Enfuvirtide

ClinicalTrials.gov record NCT00487188

PeptideScanner retained ClinicalTrials.gov record NCT00487188 at 2026-11-16T01:41:15.051Z. Its registry update date was 2015-08-13, and PeptideScanner's reviewed identity mapping was enfuvirtide.

Source: ClinicalTrials.gov ↗

→

July 2015

5 records

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00473265

PeptideScanner retained ClinicalTrials.gov record NCT00473265 at 2026-07-30T21:41:27.762Z. Its registry update date was 2015-07-16, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Thymosin beta-4

ClinicalTrials.gov record NCT01387347

PeptideScanner retained ClinicalTrials.gov record NCT01387347 at 2026-11-16T01:44:56.605Z. Its registry update date was 2015-07-10, and PeptideScanner's reviewed identity mapping was thymosin-beta-4.

Source: ClinicalTrials.gov ↗

→

June 2015

13 records

Literature metadata · Nesiritide

Natriuretic peptides for the treatment of acute heart failure: a focus on nesiritide in recent clinical trials.

PubMed lists PMID 26028173 in Expert review of cardiovascular therapy as Journal Article, Review, with publication-date metadata of 2015-05-31 (day precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Degarelix

Gonadotropin-releasing hormone receptor-targeted paclitaxel-degarelix conjugate: synthesis and in vitro evaluation.

PubMed lists PMID 25851250 in Journal of peptide science : an official publication of the European Peptide Society as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-04-08 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Glatiramer acetate

ClinicalTrials.gov record NCT01317004

PeptideScanner retained ClinicalTrials.gov record NCT01317004 at 2026-11-16T17:42:50.457Z. Its registry update date was 2015-06-22, and PeptideScanner's reviewed identity mapping was glatiramer-acetate.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Albiglutide

Apremilast, albiglutide, and empagliflozin.

PubMed lists PMID 25216888 in Journal of the American Pharmacists Association : JAPhA as Journal Article, with publication-date metadata of 2014 Sep-Oct (source-text precision). PeptideScanner associated the retained record with the identity slug albiglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Terlipressin

ClinicalTrials.gov record NCT00986817

PeptideScanner retained ClinicalTrials.gov record NCT00986817 at 2026-11-15T21:47:40.408Z. Its registry update date was 2015-06-15, and PeptideScanner's reviewed identity mapping was terlipressin.

Source: ClinicalTrials.gov ↗

→

Literature metadata · GHK-Cu

PubMed record PMID 25731775

PeptideScanner retained PubMed bibliographic metadata for PMID 25731775 at 2026-07-30T21:43:30.952Z. PubMed recorded a metadata revision date of 2015-06-02 and an Entrez history date of 2015-03-04. PeptideScanner associated this retained record with the identity slug ghk-cu. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

May 2015

12 records

Literature metadata · Mecasermin

Desensitization to mecasermin in an insulin-like growth factor 1-deficient patient.

PubMed lists PMID 25843163 in Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology as Case Reports, Letter, with publication-date metadata of 2015-04-03 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Exenatide

PubMed record PMID 25998595

PeptideScanner retained PubMed bibliographic metadata for PMID 25998595 at 2026-07-30T21:43:30.962Z. PubMed recorded a metadata revision date of 2015-05-22 and an Entrez history date of 2015-05-23. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Regulatory · Pasireotide

Federal Register notice 2015-10994

The Federal Register published notice 2015-10994, attributed to FDA and its parent HHS department, on 2015-05-07. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; SIGNIFOR,” and PeptideScanner's exact reviewed identity mapping connects the document to Pasireotide.

Source: Federal Register via GovInfo ↗

→

Regulatory · Teduglutide

Federal Register notice 2015-11000

The Federal Register published notice 2015-11000, attributed to FDA and its parent HHS department, on 2015-05-07. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; GATTEX,” and PeptideScanner's exact reviewed identity mapping connects the document to Teduglutide.

Source: Federal Register via GovInfo ↗

→

Regulatory · Triptorelin

Federal Register notice 2015-11003

The Federal Register published notice 2015-11003, attributed to FDA and its parent HHS department, on 2015-05-07. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; OVUGEL,” and PeptideScanner's exact reviewed identity mapping connects the document to Triptorelin.

Source: Federal Register via GovInfo ↗

→

April 2015

13 records

Regulatory · Oxytocin

Federal Register notice 2015-09299

The Federal Register published notice 2015-09299, attributed to FDA and its parent HHS department, on 2015-04-22. Its official title is “Determination That OXYTOCIN in 5% Dextrose Injection Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.

Source: Federal Register via GovInfo ↗

→

Regulatory · Glatiramer acetate

Drugs@FDA application ANDA090218

The official Drugs@FDA dataset lists original submission 1 for ANDA 090218 with status AP dated 2015-04-16, and names glatiramer acetate among the application record's active ingredients.

Source: Drugs@FDA via openFDA ↗

→

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01473589

PeptideScanner retained ClinicalTrials.gov record NCT01473589 at 2026-07-30T21:42:40.788Z. Its registry update date was 2015-04-16, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01473602

PeptideScanner retained ClinicalTrials.gov record NCT01473602 at 2026-07-30T21:42:40.804Z. Its registry update date was 2015-04-16, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT02416271

PeptideScanner retained ClinicalTrials.gov record NCT02416271 at 2026-07-30T21:42:40.803Z. Its registry update date was 2015-04-14, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

→

March 2015

10 records

February 2015

1 record

January 2015

7 records

Clinical trials · Glatiramer acetate

ClinicalTrials.gov record NCT00451451

PeptideScanner retained ClinicalTrials.gov record NCT00451451 at 2026-11-16T17:42:50.457Z. Its registry update date was 2015-01-26, and PeptideScanner's reviewed identity mapping was glatiramer-acetate.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Vasopressin

ClinicalTrials.gov record NCT00748072

PeptideScanner retained ClinicalTrials.gov record NCT00748072 at 2026-11-15T22:08:31.832Z. Its registry update date was 2015-01-13, and PeptideScanner's reviewed identity mapping was vasopressin.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Dulaglutide

PubMed record PMID 25575154

PeptideScanner retained PubMed bibliographic metadata for PMID 25575154 at 2026-07-30T21:44:40.387Z. PubMed recorded a metadata revision date of 2015-01-10 and an Entrez history date of 2015-01-10. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→